Nav: Home

One monoclonal antibody protects against 2 lethal viruses

April 05, 2017

A new study reports that one human monoclonal antibody therapy protected nonhuman primates from the lethal hemorrhagic fevers caused by both Marburg and Ravn viruses. Since the first recognized outbreak of Marburg virus disease in 1967, the illness has proven fatal in roughly 80% of infected individuals, and no clinically approved approaches (including vaccines) currently exist. This gap in treatment options makes outbreaks even more difficult to detect and control, because infected individuals often don't report to clinics and unintentionally transmit the diseases to others. Similar to Ebola virus - a related member of the filovirus family - Marburg and Ravn viruses cause highly dangerous infections that can lead to fevers, vomiting, severe diarrhea, internal bleeding, and in many cases, death. What's more, the recent 2013 to 2016 Ebola epidemic further highlighted a troubling absence of preventative and therapeutic regimens to combat filoviruses. In search of a viable therapy, Chad Mire and colleagues showed that one of the antibodies (called MR191-N) that was previously isolated from the serum of a patient who survived Marburg virus disease prevented lethality in guinea pigs and nonhuman primates infected with Marburg and Ravn viruses. Importantly, nonhuman primates that received two doses of MR191-N at four and seven days after infection were able to clear the viruses, and 100% remained alive, whereas control animals all succumbed to their infections. The researchers say that before MR191 can be tested in a clinical setting, additional pharmacology and toxicology testing, as well as development under Good Manufacturing Practices, will be required.
-end-


American Association for the Advancement of Science

Related Viruses Articles:

First video of viruses assembling
For the first time, researchers have captured images of the formation of individual viruses, offering a real-time view into the kinetics of viral assembly.
Plant viruses may be reshaping our world
A new review article appearing in the journal Nature Reviews Microbiology highlights the evolution and ecology of plant viruses.
Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.
How viruses outsmart their host cells
Viruses depend on host cells for replication, but how does a virus induce its host to transcribe its own genetic information alongside that of the virus, thus producing daughter viruses?
Mobile, instant diagnosis of viruses
In a first for plant virology, a team from CIRAD recently used nanopore technology to sequence the entire genomes of two yam RNA viruses.
More Viruses News and Viruses Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...